BioCorRx (BICX) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$808502.0.
- BioCorRx's Net Income towards Common Stockholders rose 4656.33% to -$808502.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 1389.53%. This contributed to the annual value of -$5.1 million for FY2024, which is 3555.19% down from last year.
- According to the latest figures from Q3 2025, BioCorRx's Net Income towards Common Stockholders is -$808502.0, which was up 4656.33% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, BioCorRx's Net Income towards Common Stockholders registered a high of -$808502.0 during Q3 2025, and its lowest value of -$1.6 million during Q1 2021.
- Its 5-year average for Net Income towards Common Stockholders is -$1.1 million, with a median of -$1.2 million in 2022.
- Per our database at Business Quant, BioCorRx's Net Income towards Common Stockholders crashed by 7444.09% in 2024 and then surged by 4656.33% in 2025.
- Quarter analysis of 5 years shows BioCorRx's Net Income towards Common Stockholders stood at -$1.3 million in 2021, then rose by 8.36% to -$1.2 million in 2022, then increased by 16.68% to -$969009.0 in 2023, then decreased by 26.69% to -$1.2 million in 2024, then skyrocketed by 34.14% to -$808502.0 in 2025.
- Its Net Income towards Common Stockholders stands at -$808502.0 for Q3 2025, versus -$1.4 million for Q2 2025 and -$851764.0 for Q1 2025.